scispace - formally typeset
K

Kazimierz Haberka

Researcher at Jagiellonian University Medical College

Publications -  14
Citations -  77

Kazimierz Haberka is an academic researcher from Jagiellonian University Medical College. The author has contributed to research in topics: Population & Sinus rhythm. The author has an hindex of 5, co-authored 14 publications receiving 59 citations.

Papers
More filters
Journal ArticleDOI

Venous Stenosis and Occlusion in the Presence of Endocardial Leads.

TL;DR: The presence of endocardial leads is a predisposing factor for venous stenosis/occlusion and increases the risk 4-fold among patients with diabetes mellitus and in patients with endocardials divided into I A and I B according to venous patency diabetes mell Titus was proved to be the only protective factor.
Journal ArticleDOI

Venous stenosis and occlusion in the presence of endocardial leads in patients referred for transvenous lead extraction.

TL;DR: Diabetes proved to have a protective effect on venous patency in the previously mentioned group and VSO does not influence the effectiveness, safety, and the use of additional tools during TLE procedures.
Journal ArticleDOI

Lead-related complications after DDD pacemaker implantation.

TL;DR: Atrial lead position was a predictive factor for lead dislodgement, while age at implantation, polyurethane 80A insulation, subclavian vein access, unipolar lead construction, and lead manufacturer were multivariate predictors of lead failure.
Journal ArticleDOI

The analysis of indications and early results of transvenous lead extraction in patients with a pacemaker, ICD and CRT - single-center experience.

TL;DR: Transvenous lead extraction has a high success rate and a low complication rate and low body mass index (BMI) was associated with a higher rate of complications.
Journal ArticleDOI

Gender differences in dual-chamber pacemaker implantation indications and long-term outcomes.

TL;DR: There is an association between gender and indications to DDD pacing therapy and the rate of adverse events was similar in both genders, and in the group without prior paroxysmal AF, women developed permanent AF more frequently.